Kingsway Biotech (01548): Legend Biotech announced the latest data from the CARTITUDE-1 study using CARVYKTI for the treatment at the 2025 American Society of Clinical Oncology Annual Meeting.

Zh tng cijng APP xn, jns ru shngw kj (01548) fb gnggo, gi gngs linyng gngs chunq shngw y 2025 nin 6 yu 3 r (niyu shjin) y xing migu zhngqun jioy wiyunhu tgng 6-K biog, bng fb xnwn go gngble CARTITUDE-1 ynji de zuxn zlio, xinshle jn jishu dnc CARVYKTI (xd j o lnsi, cilta-cel) sh zh, wi jishu wich zhl hu hux g x lngh zhl de chngq jigu.